Leerink Partners maintained a Market Perform rating on CVS Health (NYSE:CVS) shares while increasing the price target from ...

Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

European issuers initially struggled to adapt to the higher cost of funding after a decade of zero to negative interest rates ...

So far this year, closures continue to climb. Retailers have already announced 1,925 store closures so far in 2025 — and that ...

Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...

Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...

Check the time stamp on this data. Updated AI-Generated Signals for Cvs Health Corporation (CVS) available here: CVS. Type a ...

Abby Jones’ first stop of the day delivering medication was the home of 90-year-old Sarah Campbell Kier. “Come in!” yelled ...

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.